scAAV-Cre (AAV Serotype 2, Self-complementary)

Product Category:
Pre-made recombinant self-complementary AAV | scAAV-CMV-Cre | scAAV-Cre | scAAV2-CMV-Cre
Description:
scAAV2-Cre is a pre-packaged self-complementary recombinant AAV based on serotype 2, incorporating an AAV2 capsid and AAV2 inverted terminal repeats (ITRs). It drives robust expression of Cre recombinase under the control of the CMV promoter. This vector is widely used in Cre–lox systems to mediate site-specific recombination between loxP sites in cultured cells and animal models. Supplied in a ready-to-use format, it enables efficient and reproducible genetic manipulation in vitro and in vivo.
Titer: >1E+13 VG/mL
Size: 30 µL (Std Pack)
Reconstitution Buffer: Sterile PBS supplemented with final 0.005% Pluronic F-68 and 200 mM NaCl
CITATIONS
| Shipping Weight | 6 lbs |
|---|---|
| Unit Size | 30 µL at >10¹³ VG/mL, 10 µL at >10¹³ VG/mL |
Customers who bought this product also purchased…
-
SL101283-SCscAAV-Cre (AAV Serotype 3, Self-complementary)$488.00Add to cart This product has multiple variants. The options may be chosen on the product page
-
SL100500GenJet™ Plus In Vivo DNA Transfection Reagent$218.00Add to cart This product has multiple variants. The options may be chosen on the product page
-
SL100813AAV-Cre (AAV Serotype 2)$488.00Add to cart This product has multiple variants. The options may be chosen on the product page
-
SL100839AAV-Null (AAV Serotype 9)$488.00Add to cart This product has multiple variants. The options may be chosen on the product page
-
SL116010AAV-CAG-GFP (AAV Serotype PHP.eB)$488.00Add to cart This product has multiple variants. The options may be chosen on the product page
-
SL100811AAV-Null (AAV Serotype 2)$488.00Add to cart This product has multiple variants. The options may be chosen on the product page
-
SL100897AAV-CAG-ChR2(H134R)-tdTOMATO (AAV Serotype 2)$488.00Add to cart This product has multiple variants. The options may be chosen on the product page
Custom Service Solutions
Looking for a customized solution? Our end-to-end capabilities support both in vitro and in vivo applications, with rigorous quality control, scalable production processes, and expert scientific oversight at every stage.


